Bessemer Group
OPRX icon

Bessemer Group’s OptimizeRx OPRX Stock Holding History

Bessemer Group’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20
Closed – – 2154
2023
Q4 		$0 Hold
20
– – ﹤0.01% 2239
2023
Q3 		$0 Hold
20
– – ﹤0.01% 2283
2023
Q2 		$0 Hold
20
– – ﹤0.01% 2322
2023
Q1 		$0 Hold
20
– – ﹤0.01% 2020
2022
Q4 		$0 Hold
20
– – ﹤0.01% 2083
2022
Q3 		$0 Hold
20
– – ﹤0.01% 2123
2022
Q2 		$1K Hold
20
– – ﹤0.01% 1824
2022
Q1 		$1K Sell
20
-400
-95% -$17.7K ﹤0.01% 1783
2021
Q4 		$26K Buy
420
+20
+5% +$1.52K ﹤0.01% 1227
2021
Q3 		$34K Sell
400
-200
-33% -$12.5K ﹤0.01% 1131
2021
Q2 		$37K Sell
600
-665
-53% -$33.8K ﹤0.01% 1125
2021
Q1 		$62K Sell
1,265
-135
-10% -$6.51K ﹤0.01% 971
2020
Q4 		$44K Sell
1,400
-400
-22% -$9.8K ﹤0.01% 1014
2020
Q3 		$38K Sell
1,800
-900
-33% -$15.5K ﹤0.01% 961
2020
Q2 		$35K Buy
+2,700
New +$29.4K ﹤0.01% 1394

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Bessemer Group's OPRX Position: Q1 2024 in Review

Bessemer Group sold out of OptimizeRx (OPRX) in Q1 2024, closing a stake of 20 shares.

Bessemer Group first reported a position in OPRX in Q2 2020 and held it in 15 quarters. The position peaked at $62K in Q1 2021. 97 funds tracked by Wall St. Rank hold OPRX as of Q1 2024.

  • Bessemer Group reported no remaining OptimizeRx position as of Q1 2024 after selling out during the quarter.
  • Bessemer Group sold 20 OptimizeRx shares in Q1 2024.
  • Bessemer Group first reported a position in OptimizeRx in Q2 2020 and held it in 15 quarters.
  • Bessemer Group's OptimizeRx position peaked at $62K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2024.

Based on Bessemer Group's 13F filing for Q1 2024, filed 13 May 2024.